1.3 361.6 Selling Expenses 63.6 73.1 (12.9) Administrative Expenses 32.8 46.5 (29.4) Foreign Exchange Loss 74.2 - 100.0 Finance Costs 4.2 4.8 (13.1) Total Expenses 404.4 426.8 (5.2) Cost of Goods Sold
1.09 million from the same period of 2017. This was due gain on short- term investment of THB 0.77 million. Costs and Gross Profit 1. Program Rights Business Costs of program rights business consist
and beverages 258.3 35.4% 277.2 36.6% Other operating expenses 293.9 40.3% 306.7 40.5% Costs of Sales and Service 552.2 75.7% 583.9 77.2% Gross Profit (After deduct Costs of foods and beverages) 471.1
nearly the same as Q1/2017. Costs and Expenses In Q1/2018, total costs and expenses 163 million Baht decreased by 83 million Baht (34%) from Q1/2017. Main course items are from decreasing of work volume
. Interest and other income of Q2/2017 amount 4 million Baht increased 1 million Baht. Foreign exchange gain of Q2/2017 amount 1 million Baht nearly same Q2/2016. Costs and Expenses In Q2/2017, total costs and
selling medical equipment 60.65 73.92 Administrative expenses 109.64 105.99 Finance costs 22.86 24.24 Finance costs (net) 20.87 21.71 Proportion of cost of medical treatment / revenue of medical treatment
590.59 553.11 Cost of selling medical equipment 65.30 57.70 Administrative expenses 112.97 109.49 Finance costs 19.32 24.93 Finance costs (net) 16.90 22.87 Proportion of cost of medical treatment / revenue
considered a post-employment benefits plan amendment. The effect of the change is recognized past service costs as expenses in the income statement . The Company and its subsidiaries recognize the increase in
depreciation expenses. Compared with the administrative expenses in 1Q19, an increase of Baht 3.55 million or 10.99% is observed, and this is mainly due to an increase in the reclassification of fixed costs at
an increase in the overall costs of production per unit in 1H17. Selling Expenses Selling expenses in 2Q18 were in the amount of Baht 21.34 million which increased by Baht 4.54 million or 27.02% as